BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...
SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...
WASHINGTON, DC—Single antiplatelet therapy may be a reasonable antithrombotic choice for some patients with atrial fibrillation who undergo left atrial appendage (LAA) occlusion, according to ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...
(RTTNews) - Shares of Catheter Precision Inc. (VTAK) are up over 65% at $4.36, following an encouraging regulatory news related to its LockeT wound closure device. LockeT is a suture retention device ...
The device, which works like a sewing machine, can suture incision sites made during laparoscopic surgeries in less than 60 seconds. “AbCloseTM is designed to reduce time, cost and risk of port site ...
Atrial septal defect closure techniques have evolved considerably over recent decades. Traditional surgical repair, once the mainstay of treatment for congenital heart anomalies, has gradually been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results